Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

AVGR

Avinger Inc

Dec 13 • 04:00PM ET

0.6309

Dollar change -0.0080
Percentage change -1.25	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: BSX ISRG EW ABT RMD PEN INSP STAA TNDM NVCR

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-12.34	Insider Own	11.43%	Shs Outstand	3.31M	Perf Week	-22.60%
Market Cap	2.06M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	2.93M	Perf Month	-23.06%
Income	-19.26M	PEG	-	EPS next Q	-	Inst Own	4.25%	Short Float	2.15%	Perf Quarter	-52.57%
Sales	7.26M	P/S	0.28	EPS this Y	-	Inst Trans	-82.51%	Short Ratio	0.25	Perf Half Y	-63.74%
Book/sh	1.39	P/B	0.45	EPS next Y	-	ROA	-118.36%	Short Interest	0.06M	Perf Year	-78.83%
Cash/sh	1.80	P/C	0.35	EPS next 5Y	-	ROE	-1476.32%	52W Range	0.39 - 5.45	Perf YTD	-76.72%
Dividend Est.	-	P/FCF	-	EPS past 5Y	70.26%	ROI	-470.70%	52W High	-88.42%	Beta	1.18
Dividend TTM	-	Quick Ratio	0.81	Sales past 5Y	0.22%	Gross Margin	20.94%	52W Low	61.77%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	1.21	EPS Y/Y TTM	62.60%	Oper. Margin	-240.98%	RSI (14)	26.65	Volatility	20.85% 9.50%
Employees	72	Debt/Eq	1.44	Sales Y/Y TTM	-6.26%	Profit Margin	-265.23%	Recom	1.00	Target Price	5.00
Option/Short	No / Yes	LT Debt/Eq	0.06	EPS Q/Q	37.61%	Payout	-	Rel Volume	1.34	Prev Close	0.64
Sales Surprise	0.92%	EPS Surprise	10.34%	Sales Q/Q	-9.19%	Earnings	Nov 07 AMC	Avg Volume	249.65K	Price	0.63
SMA20	-20.36%	SMA50	-24.46%	SMA200	-66.92%	Trades		Volume	335,223	Change	-1.25%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-29-21	Initiated	B. Riley Securities	Buy	$2.50
Mar-09-18	Initiated	Ladenburg Thalmann	Buy
Apr-12-17	Downgrade	Oppenheimer	Outperform → Perform
Apr-11-17	Downgrade	Canaccord Genuity	Buy → Hold	$4.30 → $1
Dec-29-15	Downgrade	Dougherty & Company	Buy → Neutral
May-08-15	Reiterated	Dougherty & Company	Buy	$16 → $18
Apr-29-15	Initiated	Dougherty & Company	Buy	$16
Feb-24-15	Initiated	Oppenheimer	Outperform	$15
Feb-24-15	Initiated	Canaccord Genuity	Buy	$18

Nov-08-24 11:24AM	Q3 2024 Avinger Inc Earnings Call (Thomson Reuters StreetEvents)
02:28AM	Avinger Inc (AVGR) Q3 2024 Earnings Call Highlights: Strategic Realignment and Product Launches ... (GuruFocus.com)
Nov-07-24 05:35PM	Avinger (AVGR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:26PM	Avinger: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Avinger Reports Third Quarter 2024 Results (ACCESSWIRE)
07:56AM	Loading…
Nov-06-24 07:56AM	Avinger Inc (AVGR) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-29-24 08:00AM	Avinger to Announce Third Quarter 2024 Results on November 7, 2024 (ACCESSWIRE)
Oct-24-24 08:00AM	Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention (ACCESSWIRE)
Sep-18-24 08:00AM	Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents (ACCESSWIRE)
Aug-21-24 11:11AM	Avinger (AVGR) Launches Pantheris LV to Boost PAD Treatment (Zacks) +7.02%
Aug-20-24 08:30AM	Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device (ACCESSWIRE)
Aug-08-24 09:58PM	AVGR Stock Earnings: Avinger Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace)
05:20PM	Avinger (AVGR) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:13PM	Avinger: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Avinger Reports Second Quarter 2024 Results (ACCESSWIRE)
08:00AM	Loading…
Aug-05-24 08:00AM	Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer (ACCESSWIRE) -9.29%
Jul-29-24 08:45AM	Avinger to Announce Second Quarter 2024 Results on August 8, 2024 (ACCESSWIRE) -9.86%
Jul-26-24 07:36AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) -11.80%
Jun-17-24 04:05PM	Avinger Announces Closing of up to $24 Million Public Offering (ACCESSWIRE) +5.08%
Jun-14-24 08:00AM	Avinger Announces Pricing of up to $24 Million Public Offering (ACCESSWIRE)
Jun-05-24 07:30AM	Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business (ACCESSWIRE) +7.41%
May-17-24 09:40AM	Are Medical Stocks Lagging Avinger (AVGR) This Year? (Zacks)
May-16-24 04:05PM	Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity (ACCESSWIRE)
11:01AM	Avinger Inc (AVGR) Q1 2024 Earnings Call Transcript Highlights: Strategic Partnerships and ... (GuruFocus.com)
May-15-24 08:54PM	AVGR Stock Earnings: Avinger Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
05:26PM	Avinger: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Avinger Reports First Quarter 2024 Results (ACCESSWIRE)
May-07-24 08:15AM	Avinger to Announce First Quarter 2024 Results on May 15, 2024 (ACCESSWIRE)
Apr-15-24 08:51AM	Fast-paced Momentum Stock Avinger (AVGR) Is Still Trading at a Bargain (Zacks) -13.89%
Mar-25-24 12:00PM	Avinger (AVGR) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
10:23AM	Loading…
Mar-21-24 10:23AM	Avinger, Inc. (NASDAQ:AVGR) Q4 2023 Earnings Call Transcript (Insider Monkey) -11.52%
Mar-20-24 08:53PM	AVGR Stock Earnings: Avinger Misses Revenue for Q4 2023 (InvestorPlace) +6.45%
04:40PM	Avinger: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Avinger Reports Fourth Quarter and Full Year 2023 Results (ACCESSWIRE)
Mar-12-24 09:00AM	Avinger to Announce Full Year 2023 Results on March 20, 2024 (ACCESSWIRE) -6.34%
Mar-06-24 07:30PM	Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge (ACCESSWIRE) -10.81%
Oct-27-23 08:24AM	Avinger, Inc. (NASDAQ:AVGR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-26-23 06:40PM	Avinger (AVGR) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
05:33PM	Avinger: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Avinger Reports Third Quarter 2023 Results (ACCESSWIRE)
Oct-19-23 08:00AM	Avinger to Announce Third Quarter 2023 Results on October 26 (ACCESSWIRE)
Sep-27-23 08:00AM	Avinger Raises $5.3 Million via At-The-Market Facility (ACCESSWIRE) -13.67%
Sep-18-23 08:00AM	Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device (ACCESSWIRE) +46.80%
Aug-25-23 12:38PM	Unmasking the Value Trap: A Deep Dive into Avinger Inc (AVGR) (GuruFocus.com) -11.55%
Aug-24-23 08:00AM	Avinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023 (ACCESSWIRE)
Aug-04-23 09:00AM	Avinger Announces Conversion of 12% of CRG Term Debt into Equity (ACCESSWIRE)
Jul-28-23 06:15AM	Q2 2023 Avinger Inc Earnings Call (Thomson Reuters StreetEvents) -16.87%
Jul-27-23 06:35PM	Avinger (AVGR) Reports Q2 Loss, Misses Revenue Estimates (Zacks) +8.97%
05:33PM	Avinger: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Avinger Reports Second Quarter 2023 Results (ACCESSWIRE)
Jul-20-23 08:00AM	Avinger to Announce Second Quarter 2023 Results on July 27 (ACCESSWIRE) +16.67%
Jun-20-23 08:00AM	Avinger Announces Presentations by Key Opinion Leaders at LINC 2023 (ACCESSWIRE) +5.39%
Jun-09-23 08:00AM	Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference (ACCESSWIRE)
Jun-07-23 08:00AM	Avinger Receives 510(k) Clearance for Pantheris LV Image-Guided Atherectomy System (ACCESSWIRE)
Jun-05-23 08:00AM	Avinger Announces Successful First Cases with Tigereye ST Image-Guided Chronic Total Occlusion (CTO) Crossing Device (ACCESSWIRE) +7.66%
May-11-23 05:28AM	Q1 2023 Avinger Inc Earnings Call (Thomson Reuters StreetEvents) -5.77%
May-10-23 04:36PM	Avinger: Q1 Earnings Snapshot (AP Finance) +7.42%
04:01PM	Avinger Reports First Quarter 2023 Results (ACCESSWIRE)
May-02-23 08:00AM	Avinger to Announce First Quarter 2023 Results on May 10 (ACCESSWIRE)
Apr-28-23 08:00AM	Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium (ACCESSWIRE) -11.22%
Apr-26-23 08:00AM	Avinger Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System (ACCESSWIRE) +13.51%
Mar-16-23 07:35AM	Q4 2022 Avinger Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-15-23 04:20PM	Avinger: Q4 Earnings Snapshot (AP Finance)
04:01PM	Avinger Reports Fourth Quarter 2022 Results (ACCESSWIRE)
Mar-02-23 08:00AM	Avinger to Announce Fourth Quarter 2022 Results on March 15 (ACCESSWIRE)
Jan-11-23 08:15AM	Avinger Announces 510(k) Filing of Pantheris LV (ACCESSWIRE) +7.09%
Nov-12-22 08:02AM	Avinger Third Quarter 2022 Earnings: US$0.77 loss per share (vs US$1.25 loss in 3Q 2021) (Simply Wall St.)
Nov-09-22 04:01PM	Avinger Reports Third Quarter 2022 Results (ACCESSWIRE) +5.34%
Nov-04-22 08:00AM	Avinger Announces Issuance of Seven New Patents Expanding Coverage for Its Proprietary Image-Guided Atherectomy Devices (ACCESSWIRE)
Nov-01-22 07:45AM	Avinger to Announce Third Quarter 2022 Results on November 9 (ACCESSWIRE)
Oct-19-22 08:00AM	Avinger to Present at LD Micro Investor Conference (ACCESSWIRE)
Sep-07-22 08:30AM	BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council (GlobeNewswire)
Sep-01-22 08:00AM	Interim Data from IMAGE-BTK Clinical Trial Presented at AMP 2022 (ACCESSWIRE)
Aug-11-22 04:30PM	Edited Transcript of AVGR.OQ earnings conference call or presentation 11-Aug-22 8:30pm GMT (Thomson Reuters StreetEvents)
04:05PM	Avinger Reports Second Quarter 2022 Results (ACCESSWIRE)
Aug-08-22 03:15PM	Avinger, Inc. Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-the-Market Under Nasdaq Rules (ACCESSWIRE) +5.59%
Aug-05-22 08:00AM	Avinger to Announce Second Quarter 2022 Results on August 11 (ACCESSWIRE)
Aug-04-22 08:00AM	Avinger Announces $5 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules (ACCESSWIRE)
Jul-06-22 08:00AM	Avinger Announces Filing of 510(k) Submission for Tigereye ST Image-Guided CTO Crossing System (ACCESSWIRE)
Jun-21-22 07:30AM	Avinger Expands International Presence with First Commercial Shipment to Chile (ACCESSWIRE)
Jun-15-22 08:30AM	Avinger Announces Presentations by Key Opinion Leaders and Live Case Transmission at LINC 2022 (ACCESSWIRE) +6.85%
Jun-06-22 08:30AM	Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference (ACCESSWIRE)
May-16-22 08:00AM	Avinger Announces Key Opinion Leader Presentation and Live Case at Vascular Conferences in Germany (ACCESSWIRE)
May-10-22 05:55PM	Avinger (AVGR) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -27.35%
04:02PM	Avinger Reports First Quarter 2022 Results (ACCESSWIRE)
May-04-22 07:45PM	AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -8.25%
Apr-29-22 09:00AM	Avinger to Announce First Quarter 2022 Results on May 10 (ACCESSWIRE)
Apr-19-22 08:00AM	Avinger Announces Full Commercial Launch of Lightbox 3 (ACCESSWIRE)
Mar-30-22 08:00AM	Avinger Announces Issuance of Three New U.S. Patents in March 2022 (ACCESSWIRE) +10.29%
Mar-29-22 04:05PM	Avinger Regains Compliance with Nasdaq Listing Requirements (ACCESSWIRE) +6.71%
Mar-22-22 05:15PM	Avinger (AVGR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Avinger Reports Fourth Quarter and Year End 2021 Results (ACCESSWIRE)
Mar-15-22 07:30AM	Avinger to Announce Full-Year 2021 Results on March 22 (ACCESSWIRE) -15.83%
Mar-14-22 08:00AM	Avinger to Effect One-for-Twenty Reverse Stock Split (ACCESSWIRE) -26.29%
Mar-08-22 08:55AM	Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +7.66%
Mar-07-22 07:30AM	Avinger Expands Lightbox 3 First Case Experience (ACCESSWIRE) -7.74%
Mar-02-22 07:58AM	Health Check: How Prudently Does Avinger (NASDAQ:AVGR) Use Debt? (Simply Wall St.) -6.18%
Feb-28-22 08:15AM	Avinger Announces Successful Completion of First Cases with the Lightbox 3 Next Generation Imaging Console (ACCESSWIRE) +13.04%
Feb-24-22 05:30PM	Natus Medical (NTUS) Beats Q4 Earnings and Revenue Estimates (Zacks)
Feb-22-22 05:55PM	Tactile Systems Technology (TCMD) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -6.90%

Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Wildcat, Juicebox, and Kittycat. The company was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AVGR

Avinger Inc

Upgrade your FINVIZ experience